SMTL ID : 2e1w.1

Crystal structure of adenosine deaminase complexed with potent inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: H.14, H.16, H.213, H.237, D.294 Ligands: FR6.2 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.14, A:H.16, A:D.294, H2O.5

1 x FR6: 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}-1H-IMIDAZOLE-4-CARBOXAMIDE(Non-covalent)

FR6.2: 16 residues within 4Å: Chain A: H.16, D.18, F.60, L.61, F.64, Y.101, L.105, W.116, M.154, H.156, A.182, G.183, D.184, D.294, D.295 Ligands: ZN.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.61, A:W.116, A:A.182, A:D.184 Hydrogen bonds: A:D.18, A:D.295 Water bridges: A:S.102 pi-Stacking: A:H.16

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Terasaka, T. et al., Structure-Based Design and Synthesis of Non-Nucleoside, Potent, and Orally Bioavailable Adenosine Deaminase Inhibitors. J.Med.Chem. (2004)

Release Date

2006-11-07

Peptides

Adenosine deaminase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Adenosine deaminase

Related Entries With Identical Sequence